Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>Deep learning models have had a great success in disease classifications using large data pools of skin cancer images or lung X‐rays. However, data scarcity has been the roadblock of applying deep learning models directly on prostate multiparametric MRI (mpMRI). Although model interpretation has been heavily studied for natural images for the past few years, there has been a lack of interpretation of deep learning models trained on medical images.</p><p>In this paper, an efficient convolutional neural network (CNN) was developed and the model interpretation at various convolutional layers was systematically analyzed to improve the understanding of how CNN interprets multimodality medical images and the predictive powers of features at each layer. The problem of small sample size was addressed by feeding the intermediate features into a traditional classification algorithm known as weighted extreme learning machine (wELM), with imbalanced distribution among output categories taken into consideration.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The training data collection used a retrospective set of prostate MR studies, from SPIE‐AAPM‐NCI PROSTATEx Challenges held in 2017. Three hundred twenty biopsy samples of lesions from 201 prostate cancer patients were diagnosed and identified as clinically significant (malignant) or not significant (benign). All studies included T2‐weighted (T2W), proton density‐weighted (PD‐W), dynamic contrast enhanced (DCE) and diffusion‐weighted (DW) imaging. After registration and lesion‐based normalization, a CNN with four convolutional layers were developed and trained on 10‐fold cross validation. The features from intermediate layers were then extracted as input to wELM to test the discriminative power of each individual layer. The best performing model from the 10 folds was chosen to be tested on the holdout cohort from two sources. Feature maps after each convolutional layer were then visualized to monitor the trend, as the layer propagated. Scatter plotting was used to visualize the transformation of data distribution. Finally, a class activation map was generated to highlight the region of interest based on the model perspective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Experimental trials indicated that the best input for CNN was a modality combination of T2W, apparent diffusion coefficient (ADC) and DWIb50. The convolutional features from CNN paired with a weighted extreme learning classifier showed substantial performance compared to a CNN end‐to‐end training model. The feature map visualization reveals similar findings on natural images where lower layers tend to learn lower level features such as edges, intensity changes, etc, while higher layers learn more abstract and task‐related concept such as the lesion region. The generated saliency map revealed that the model was able to focus on the region of interest where the lesion resided and filter out background information, including prostate boundary, rectum, etc.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>This work designs a customized workflow for the small and imbalanced data set of prostate mpMRI where features were extracted from a deep learning model and then analyzed by a traditional machine learning classifier. In addition, this work contributes to revealing how deep learning models interpret mpMRI for prostate cancer patients stratification.</p></section>

Saliency Transfer Learning and Central-Cropping Network for Prostate Cancer Classification

Attention-guided multi-scale learning network for automatic prostate and tumor segmentation on MRI

Prostate cancer detection and segmentation on MRI using non‐local mask R‐CNN with histopathological ground truth

Automated diagnosis of prostate cancer in multi-parametric MRI based on multimodal convolutional neural networks

A hybrid classification model with radiomics and CNN for high and low grading of prostate cancer Gleason score on mp-MRI

ParaCM-PNet: A CNN-tokenized MLP combined parallel dual pyramid network for prostate and prostate cancer segmentation in MRI

Implementation of Convolutional Neural Network Architecture on 3D Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis

Prostate Lesion Detection and Salient Feature Assessment Using Zone-Based Classifiers

Classification of Prostate Cancer in 3D Magnetic Resonance Imaging Data based on Convolutional Neural Networks

3D convolutional network with edge detection for prostate gland and tumor segmentation on T2WI and ADC

A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network

A two-stage CNN method for MRI image segmentation of prostate with lesion

ProstAttention-Net: A deep attention model for prostate cancer segmentation by aggressiveness in MRI scans

Fusing hand-crafted and deep-learning features in a convolutional neural network model to identify prostate cancer in pathology images

Enhanced Cascade Prostate Cancer Classifier in mp-MRI Utilizing Recall Feedback Adaptive Loss and Prior Knowledge-Based Feature Extraction

Towards Multi-modality Fusion and Prototype-based Feature Refinement for Clinically Significant Prostate Cancer Classification in Transrectal Ultrasound

CDA-Net: A Contrastive Deep Adversarial Model for Prostate Cancer Segmentation in MRI Images.

Prostate cancer of magnetic resonance imaging automatic segmentation and detection of based on 3D-Mask RCNN

Classification of Prostate Transitional Zone Cancer and Hyperplasia Using Deep Transfer Learning from Disease-Related Images.

Z-SSMNet: Zonal-aware Self-supervised Mesh Network for Prostate Cancer Detection and Diagnosis with Bi-parametric MRI

A contrastive weakly supervised learning to characterize malignant prostate lesions in BP-MRI